Novo Nordisk Kalundborg

The world's largest insulin manufacturing site

Novo Nordisk Kalundborg is growing rapidly these years. The next ten years, a billion DKK is put into building new facilities and upgrading existing – every single year.

The site holds the largest insulin producing facility in the world – producing more than 50 % of all insulin globally, as well as our Biopharm products. We are more than 3,400 people. This is your opportunity for a life-changing career. Interested?

Take the virtual tour

See the whole site with more than 15 factories from above and go into selected spots to see some of our production system.

Employee stories

Our employees will try to convince you that Kalundborg is the center of the world, but in actuality it is just a very special place to live and work.

Hear one of our Process Responsible Chemical Engineers tell her story of working in the world's largest insulin manufacturing site and moving to Kalundborg.

Hear one of our Associate Managers tell his story of opportunities and development of employees at the world's largest insulin manufacturing site.

Hear one of our Project Managers tell his story of small and large scale facility and equipment upgrade projects at the world's largest insulin manufacturing site and living in Kalundborg.

Connect with us

Who we are

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity.

Headquartered in Denmark, Novo Nordisk employs approximately 42,600 people in 75 countries and markets its products in more than 180 countries.